5 results
Safety of Using a Combinatorial Pharmacogenomic Test for Patients with Major Depressive Disorder in the GUIDED trial
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, pp. 169-170
-
- Article
-
- You have access
- Export citation
150 HAM-D6 Outcomes in a Randomized, Controlled Trial Evaluating the Utility of Combinatorial Pharmacogenomics in Depression
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 295-296
-
- Article
-
- You have access
- Export citation
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials
-
- Journal:
- Acta Neuropsychiatrica / Volume 31 / Issue 4 / August 2019
- Published online by Cambridge University Press:
- 06 June 2019, pp. 230-234
-
- Article
- Export citation
49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 12 March 2019, pp. 202-203
-
- Article
-
- You have access
- Export citation
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder
-
- Journal:
- Acta Neuropsychiatrica / Volume 30 / Issue 5 / October 2018
- Published online by Cambridge University Press:
- 07 December 2017, pp. 297-305
-
- Article
- Export citation